Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention

Transfusion following PCI appears to be associated with an increased risk of death within 30 days. We now report that transfusion with plasma rich non-RBC products may confer an additional mortality risk to patients undergoing PCI.